https://scholars.lib.ntu.edu.tw/handle/123456789/473545
標題: | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | 作者: | I-CHUN CHEN Chang Y.-C. YEN-SHEN LU KUEI-PIN CHUNG CHIUN-SHENG HUANG TZU-PIN LU WEN-HUNG KUO Wang M.-Y. KUAN-TING KUO Wu P.-F. Hsueh T.-H. Shen C.-Y. CHING-HUNG LIN ANN-LII CHENG |
公開日期: | 2016 | 出版社: | Nature Publishing Group | 卷: | 6 | 起(迄)頁: | 21374 | 來源出版物: | Scientific Reports | 摘要: | Liver kinase B1 (LKB1) is a tumor suppressor, and its loss might lead to activation of the mammalian target of rapamycin (mTOR) and tumorigenesis. This study aimed to determine the clinical relevance of LKB1 gene and protein expression in breast cancer patients. LKB1 protein expression was evaluated using immunohistochemistry in tumors from early breast cancer patients in two Taiwanese medical centers. Data on LKB1 gene expression were obtained from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) data set. The correlations between LKB1 expression, clinicopathologic factors, and patient outcome were analyzed. LKB1 expression was significantly associated with estrogen receptor (ER) expression in 2 of the 4 cohorts, but not with other clinicopathologic factors. LKB1 expression was not a predictor for relapse-free survival, overall survival (OS), or breast cancer-specific survival. In a subgroup analysis of the two Taiwanese cohorts, high LKB1 protein expression was predictive of high OS in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients (P = 0.013). Our study results indicate that LKB1 expression is not prognostic in the whole population of breast cancer patients, but it is a potential predictor of OS in the subset of HER2-positive patients. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958787432&doi=10.1038%2fsrep21374&partnerID=40&md5=8f404e2e2c29f3a1f276726f20bef940 https://scholars.lib.ntu.edu.tw/handle/123456789/473545 |
ISSN: | 2045-2322 | DOI: | 10.1038/srep21374 | SDG/關鍵字: | epidermal growth factor receptor 2; ERBB2 protein, human; protein serine threonine kinase; STK11 protein, human; adult; aged; biosynthesis; breast tumor; cancer staging; disease free survival; female; gene expression regulation; genetics; human; middle aged; pathology; prognosis; tumor recurrence; Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Protein-Serine-Threonine Kinases; Receptor, ErbB-2 |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。